Oculogenex

About

Oculogenex is a biopharmaceutical company founded and directed by an ophthalmologist retinal surgeon with patients in mind. It was founded out of passion and frustration shared with patients losing vision due to lack of therapeutic options. We have professional and scientific experience with retinal diseases, genetic variations in retinal and optic nerve diseases. We have built a team of experts in animal models of macular degeneration, antioxidant therapies for macular degeneration, medical and surgical treatments of retinal diseases and drug delivery methods. This specialized team has been built to utilize genetic engineering technology to improve vision for patients with degenerative eye diseases.

Product

Value proposition

Novel investigational gene therapy aimed at stopping degeneration of central vision in macular degeneration and dramatically improving quality of life

Founders

• An ophthalmologist (name not explicitly stated in sources)

Products

Key features

Technologies

Target conditions

Investors

News

• Pioneering Steps in Space Toward a Cure for Blindness · 2025-03-25T00:00:00.000Z
• View From the Cupola: Hema Ramkumar - ISS National Lab · 2025-03-25T16:11:35.000Z
• Science in Space Aids Macular Degeneration - ISS National Lab · 2025-05-21T17:46:11.000Z
• Hema Ramkumar, Founder and CEO of Oculogenex - ISS National Lab · 2025-03-11T16:33:55.000Z
• NSF-Funded Companies - In the News · 2025-07-15T00:00:00.000Z
• In-Orbit Activities: The ISS As a Research Platform - ISS National Lab · 2025-01-15T00:00:00.000Z

More links

Browse similar startups

Related startups

• Ocusphere Therapeutics Inc — Hayward, CA
• Olde Del Mar Surgical — La Jolla, CA
• Onc.AI — San Carlos, CA
• OnPoint Vision, Inc. — Aliso Viejo, CA
• Oral Genome — Carlsbad, CA
• Orbits Oncology — San Francisco, CA
• Ohio Dermatology Center — Gahanna, OH
• Okaloosa Cardiology — Crestview, FL
• OMEDUS — Omaha, NE
• Omnipractice — Rockville, MD
• On The Money Medical Billing — Corbin, KY
• Oncoderm Labs — Miami, FL